STELLAR: A Phase 3, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic Astrocytoma that Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy

February 10, 2019
https://clinicaltrials.gov/ct2/results?id=NCT02796261
Cancer - Brain
Principal Investigator: Tobias Walbert, MD
Brain, Cancer, Glioma, Recurrent, Progressive
Open